• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Response to correspondence concerning: "Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients".对关于“早期使用羟氯喹而非氯喹可降低COVID-19患者入住重症监护病房的几率”的信件的回复
Int J Infect Dis. 2021 Feb;103:478-479. doi: 10.1016/j.ijid.2020.12.008. Epub 2020 Dec 9.
2
Response to "Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients".对“早期使用羟氯喹而非氯喹可降低COVID-19患者入住重症监护病房的几率”的回应。
Int J Infect Dis. 2021 Feb;103:560-561. doi: 10.1016/j.ijid.2020.12.006. Epub 2020 Dec 9.
3
Comparison of hospital treatment strategy or of treatment actually received in COVID-19?: Commenting on: Lammers AJJ, Brohet RM, Theunissen REP, Koster C, Rood R, Verhagen DWM, et al. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients. Int J Infect Dis. 2020 September.2019冠状病毒病（COVID-19）医院治疗策略或实际接受治疗情况的比较：对以下文献的评论：Lammers AJJ、Brohet RM、Theunissen REP、Koster C、Rood R、Verhagen DWM等。早期使用羟氯喹而非氯喹可降低COVID-19患者入住重症监护病房的几率。《国际传染病杂志》。2020年9月。
Int J Infect Dis. 2021 Feb;103:516. doi: 10.1016/j.ijid.2020.12.007. Epub 2020 Dec 9.
4
Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution.氯喹和羟氯喹治疗新型冠状病毒肺炎：希望与谨慎并存
Clin Toxicol (Phila). 2021 Jan;59(1):70-71. doi: 10.1080/15563650.2020.1748194. Epub 2020 Apr 2.
5
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.抗2019冠状病毒病（COVID-19）的氨基喹啉：氯喹或羟氯喹。
Int J Antimicrob Agents. 2020 Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.
6
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.在 SARS-CoV-2（COVID-19）紧急情况下预防耳毒性。
J Glob Antimicrob Resist. 2020 Dec;23:263-264. doi: 10.1016/j.jgar.2020.09.030. Epub 2020 Oct 17.
7
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.氯喹和羟氯喹治疗 COVID-19：一个永无止境的故事。
Appl Microbiol Biotechnol. 2021 Feb;105(4):1333-1343. doi: 10.1007/s00253-021-11094-4. Epub 2021 Jan 30.
8
Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.氯喹和羟氯喹在2019冠状病毒病中的应用：对医疗保健专业人员的实践启示
J Coll Physicians Surg Pak. 2020 Oct;30(10):124-128. doi: 10.29271/jcpsp.2020.supp2.124.
9
Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus?氯喹或羟氯喹对治疗新型冠状病毒肺炎患者或预防接触过该病毒的人感染是否有效？
Saudi Med J. 2021 Mar;42(3):342-343.
10
Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?使用氯喹或羟氯喹治疗新型冠状病毒肺炎：这是否符合伦理？
Cent Eur J Public Health. 2020 Sep;28(3):246-247. doi: 10.21101/cejph.a6464.

引用本文的文献

1
Azithromycin through the Lens of the COVID-19 Treatment.从新冠肺炎治疗视角看阿奇霉素
Antibiotics (Basel). 2022 Aug 5;11(8):1063. doi: 10.3390/antibiotics11081063.

Response to correspondence concerning: "Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients".

作者信息

Lammers A J J, Brohet R M, Theunissen R E P, Koster C, Rood R, Verhagen D W M, Brinkman K, Hassing R J, Dofferhoff A, El Moussaoui R, Hermanides G, Ellerbroek J, Bokhizzou N, Visser H, van den Berge M, Bax H, Postma D F, Groeneveld P H P

机构信息

Isala, Zwolle, The Netherlands.

Department of Epidemiology and Statistics, Isala Academy, Zwolle, The Netherlands.

出版信息

Int J Infect Dis. 2021 Feb;103:478-479. doi: 10.1016/j.ijid.2020.12.008. Epub 2020 Dec 9.

DOI:10.1016/j.ijid.2020.12.008
PMID:33310107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836922/
Abstract
摘要